Shanghai Pharmaceuticals Holding Co., Ltd (HKG:2607)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
11.65
-0.01 (-0.09%)
At close: Feb 27, 2026
-5.28%
Market Cap 65.44B
Revenue (ttm) 306.77B
Net Income (ttm) 6.17B
Shares Out n/a
EPS (ttm) 1.67
PE Ratio 10.61
Forward PE 11.41
Dividend 0.45 (3.86%)
Ex-Dividend Date Dec 29, 2025
Volume 2,263,674
Average Volume 1,822,444
Open 11.74
Previous Close 11.66
Day's Range 11.65 - 11.75
52-Week Range 10.06 - 13.12
Beta 0.34
RSI 42.52
Earnings Date Mar 31, 2026

About HKG:2607

Shanghai Pharmaceuticals Holding Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceutical and healthcare products in China and internationally. It operates through four segments: Production, Distribution, Retail, and Others. The company offers chemical and biological drugs, Chinese medicine, health care products, and medical devices to treat immunology, psychiatric and neurological, tumor, cardiovascular, digestive metabolism, psychoneurotic, neoplasm, respiratory system, and anti-infection diseases, as well as in... [Read more]

Sector Healthcare
Founded 1994
Employees 49,402
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 2607
Full Company Profile

Financial Performance

In 2024, HKG:2607's revenue was 275.25 billion, an increase of 5.75% compared to the previous year's 260.30 billion. Earnings were 4.55 billion, an increase of 20.82%.

Financial numbers in CNY Financial Statements

News

There is no news available yet.